Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00483977 · ClinicalTrials.gov registry record · Phase 2
A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee
A Phase 2 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 2
- Development phase
- 113
- Enrollment target
NCT00483977: Clinical Trial Phase 2 study, sponsored by Pfizer.
NCT00483977 is a Phase 2 study that was terminated before completion, run by Pfizer. The registered enrollment target is 113 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00483977, a Phase 2 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 113 participants
- Enrollment target
Study Summary
The primary aim is to assess if PF-00592379 is able to reduce pain in patients with osteoarthritis of the knee.
Interventions
- DRUG Placebo
- DRUG Oxycodone
- DRUG PF-000592379
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Why NCT00483977 stopped before completion
NCT00483977 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (15% lower).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00483977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00483977 about?
NCT00483977 is a clinical study titled "A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee". The primary aim is to assess if PF-00592379 is able to reduce pain in patients with osteoarthritis of the knee.
What is the current status of trial NCT00483977?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 113 participants. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00483977?
The interventions under investigation include: Placebo (DRUG), Oxycodone (DRUG), PF-000592379 (DRUG).
Who is sponsoring clinical trial NCT00483977?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00483977's enrollment target sits among peer trials
113 631st of 2000 higher than 1,370 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia